Treatment of influenza infection of mice by using rimantadine hydrochlorides by the aerosol and intraperitoneal routes.

Antimicrobial Agents and Chemotherapy
E L StephenJ S Walker

Abstract

Rimantadine hydrochloride was administered for 4 days in a small-particle (95% < 6.5 mum) aerosol (8.8 mg/kg per day) or intraperitoneally (40 mg/kg per day) to mice previously infected with influenza A/Aichi/2/68 (H(3)N(2)), mouse adapted. Mean time to death and incidence of survival were significantly increased in all treated groups of mice. The rate of eventual disappearance of virus from lung tissue was also accelerated by therapy. However, maximal mean virus titer per lung, and lung histopathology, did not reveal any difference between control and either group of treated mice. Aerosol therapy initiated at 72 h postinfection was as effective as that initiated at 6 h, even though lung virus titers of these mice had already peaked by 72 h. In contrast, intraperitoneal therapy initiated at 72 h was not effective in all studies.

References

Sep 1, 1971·Southern Medical Journal·G A Pankey
Dec 1, 1968·Proceedings of the Society for Experimental Biology and Medicine·J W McGahen, C E Hoffmann
Sep 1, 1966·Bacteriological Reviews·R B Hornick, H T Eigelsbach
Dec 1, 1952·A.M.A. Archives of Internal Medicine·A L BARACHG J BECK
May 15, 1964·Science·W L DAVIESC E HOFFMANN
Feb 1, 1970·Infection and Immunity·V KnightR B Couch

❮ Previous
Next ❯

Citations

Oct 31, 1981·Lancet·V KnightR B Couch
Oct 9, 2002·Proceedings of the National Academy of Sciences of the United States of America·Terrence M TumpeyChristopher F Basler
Feb 1, 1978·Antimicrobial Agents and Chemotherapy·G H ScottR F Berendt
Jan 1, 1982·Antimicrobial Agents and Chemotherapy·J F HruskaR G Douglas
Mar 4, 1977·Annals of the New York Academy of Sciences·E L StephenR F Berendt
Jan 1, 2010·Viruses·Nicole M Bouvier, Anice C Lowen
Oct 27, 2018·Expert Opinion on Drug Discovery·Edin J MifsudAeron C Hurt
Mar 4, 1977·Annals of the New York Academy of Sciences·M Tisdale, D J Bauer
Jun 30, 2019·Applied and Environmental Microbiology·Jennifer D BowlingDouglas S Reed
Jul 1, 1976·Journal of Neurology, Neurosurgery, and Psychiatry·R I Davidson
Nov 19, 2020·Vaccines·Irina V KiselevaLudmila V Puchkova
Feb 1, 1977·Journal of Clinical Microbiology·H W YoungE W Larson
Jan 1, 1976·Applied and Environmental Microbiology·E W LarsonJ S Walker

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.